asal solgel therapy performance in post operative sinus surgery patients

Phase 1

• Conditions: Chronic Rhinosinusitis; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12620000319976
• Lead Sponsor: Angelica Lynch

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-09
• Last Update Posted: 16 March 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

i.Above 18 years of age
ii.Currently fit and healthy
iii.Available for required follow up
iv.Previous endoscopic sinus surgery >6 weeks ago

Exclusion Criteria

Allergies to any of the medications being used in the trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified